Ilexgenin A
|
I648295-5mg
|
≥98% |
108524-94-3 |
5mg
|
¥ 1900.9
|
期货,请咨询 |
阿拉丁 |
Ilexgenin A
|
I648295-25mg
|
≥98% |
108524-94-3 |
25mg
|
¥ 4400.9
|
期货,请咨询 |
阿拉丁 |
Ilexgenin A
|
I648295-1mg
|
≥98% |
108524-94-3 |
1mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
Ilexgenin A
|
I648295-10mg
|
≥98% |
108524-94-3 |
10mg
|
¥ 2900.9
|
期货,请咨询 |
阿拉丁 |
IK1 inhibitor PA-6
|
I648271-5mg
|
≥99% |
500715-03-7 |
5mg
|
¥ 690.9
|
期货,请咨询 |
阿拉丁 |
IK1 inhibitor PA-6
|
I648271-50mg
|
≥99% |
500715-03-7 |
50mg
|
¥ 4100.9
|
期货,请咨询 |
阿拉丁 |
IK1 inhibitor PA-6
|
I648271-25mg
|
≥99% |
500715-03-7 |
25mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
IK1 inhibitor PA-6
|
I648271-10mg
|
≥99% |
500715-03-7 |
10mg
|
¥ 1300.9
|
期货,请咨询 |
阿拉丁 |
Implitapide
|
I648268-5mg
|
≥99% |
177469-96-4 |
5mg
|
¥ 7760.9
|
期货,请咨询 |
阿拉丁 |
Implitapide
|
I648268-10mg
|
≥99% |
177469-96-4 |
10mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
ITMN 4077
|
I648250-5mg
|
≥99% |
790305-05-4 |
5mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
ITMN 4077
|
I648250-50mg
|
≥99% |
790305-05-4 |
50mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
ITMN 4077
|
I648250-25mg
|
≥99% |
790305-05-4 |
25mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
ITMN 4077
|
I648250-10mg
|
≥99% |
790305-05-4 |
10mg
|
¥ 1200.9
|
期货,请咨询 |
阿拉丁 |
ITMN 4077
|
I648250-100mg
|
≥99% |
790305-05-4 |
100mg
|
¥ 6000.9
|
期货,请咨询 |
阿拉丁 |
IHMT-MST1-58
|
I648241-5mg
|
≥99% |
2414484-25-4 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
IHMT-MST1-58
|
I648241-50mg
|
≥99% |
2414484-25-4 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
IHMT-MST1-58
|
I648241-25mg
|
≥99% |
2414484-25-4 |
25mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
IHMT-MST1-58
|
I648241-10mg
|
≥99% |
2414484-25-4 |
10mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
Isoscabertopin
|
I648215-5mg
|
≥99% |
439923-16-7 |
5mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
Isoscabertopin
|
I648215-1mg
|
≥99% |
439923-16-7 |
1mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
5-Iodo-indirubin-3'-monoxime
|
I648181-5mg
|
≥99% |
331467-03-9 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
5-Iodo-indirubin-3'-monoxime
|
I648181-50mg
|
≥99% |
331467-03-9 |
50mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
5-Iodo-indirubin-3'-monoxime
|
I648181-10mg
|
≥99% |
331467-03-9 |
10mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |